期刊文献+

血管新生过程中CD105的表达变化及其作用 被引量:7

Expression and Function of CD105 in Angiogenesis
暂未订购
导出
摘要 目的建立基于人脐静脉内皮细胞(HUVEC)、纤维蛋白基质及微载体的体外三维新生血管模型,在此模型的基础上,研究CD105在血管新生过程中的表达变化及其作用。方法分离、纯化并培养HUVEC;建立三维新生血管模型:将HUVEC包被于微载体(Cytodex-3)上,然后将该包被有HUVEC的微载体包埋于纤维蛋白凝胶基质中,在培养体系中内皮细胞生长因子的作用下完成HUVEC的出芽、分支、连接成网等过程。通过逆转录-聚合酶链反应(RT-PCR)检测血管新生不同时期CD105的表达情况,并利用反义寡核苷酸技术干预CD105的表达,观察抑制CD105表达后HUVEC与血管新生过程的表形变化。结果包埋于三维纤维蛋白基质中的HUVEC出现出芽、分支、连接成网等典型的血管新生过程;在此过程中,CD105的表达在出芽早期及出芽分支期明显增强,而在出芽前及成网后的相对稳定期则呈不表达或弱表达状态。利用反义寡核苷酸抑制CD105表达后,HUVEC的生长及新生血管模型中的出芽、分支过程均受到明显抑制。结论CD105在血管新生的不同阶段表达水平不同,在出芽、分支期明显过表达;CD105参与了血管新生过程,抑制CD105的表达可以有效地抑制血管新生。 Objective To develop an in vitro three-dimensional angiogenesis system and analyze the expression and function of CD105 in angiogenesis.Methods After primary human umbilical vein endothelial cells(HUVEC) were purified and cultured,the microcarriers were coated with HUVEC and then embedded and cultured into fibrin gel.The angiogenesis process of HUVEC on the microcarriers was formed.The expression of CD105 during this process was detected by reverse transcription polymerase chain reaction(RT-PCR).Antisense oligodeoxynucleotide(ASODN) was used to inhibit the expression of CD105 and the changes of the angiogenesis process were analyzed quantitatively.Results HUVEC on the microcarriers which were embedded into the fibrin gel,occurred the angiogenesis process of sprouts,branches and capillary networks with lumina.During this process,CD105 was over expressed in the periods of forming sprouts and branches,and depressed in the relatively steady periods including the periods before forming sprouts and after forming capillary networks.While the expression of CD105 was inhibited by ASODN,the angiogenesis process was significantly inhibited.Conclusions The expression of CD105 is varied within the angiogenesis process,over expressing during the sprouts and branches forming periods.Inhibiting the expression of CD105 could efficiently inhibit angiogenesis.
出处 《中国普外基础与临床杂志》 CAS 2009年第10期824-829,共6页 Chinese Journal of Bases and Clinics In General Surgery
关键词 新生血管 人脐静脉内皮细胞 CD105 三维新生血管模型 微载体 Angiogenesis Human umbilical vein endothelial cell CD105 Three-dimensional angiogenesis system Microcarrier
  • 相关文献

参考文献25

  • 1Folkman J.What is the evidence that tumors are angiogenesis dependent?[J].J Natl Cancer Inst,1990;82(1):4-6.
  • 2Suh DY.Understanding angiogenesis and its clinical applications[J].Ann Clin Lab Sci,2000;30(3):227-238.
  • 3Sharma S,Sharma MC,Sarkar C.Morphology of angiogenesis in human cancer:a conceptual overview,histoprognostic perspective and significance of neoangiogenesis[J].Histopathology,2005;46(5):481-489.
  • 4骆成玉,祝学光.肿瘤血管生成对微转移影响的研究进展[J].中国普外基础与临床杂志,2003,10(5):516-518. 被引量:3
  • 5张盟辉,孔宪炳,王巧玲,阴红卫,轩诗进.射频消融联合亚砷酸局部治疗对兔肝VX2肿瘤MVD和VEGF表达的影响[J].中国普外基础与临床杂志,2007,14(1):19-22. 被引量:8
  • 6Behrem S,Zarkovic K,Eskinja N,et al.Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma[J].Croat Med J,2005;46(3):417-422.
  • 7Minhajat R,Mori D,Yamasaki F,et al.Endoglin (CD105) expression in angiogenesis of colon cancer:analysis using tissue microarrays and comparison with other endothelial markers[J].Virchows Arch,2006;448(2):127-134.
  • 8Charpin C,Dales JP,Garcia S,et al.Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays[J].Clin Cancer Res,2004;10(17):5815-5819.
  • 9Yao Y,Pan Y,Chen J,et al.Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas:analysis using tissue microarrays and comparisons with CD34 and VEGF[J].Ann Clin Lab Sci,2007;37(1):39-48.
  • 10Yao Y,Kubota T,Takeuchi H,et al.Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors:comparison with an anti-CD31 monoclonal antibody[J].Neuropathology,2005;25(3):201-206.

二级参考文献48

  • 1Saad R S, Jasnosz K M, Tung M Y, et al. Endoglin (CD105) expression in endometrial carcinoma[J].Int J Gynecol Pathol,2003,22(3):248-253.
  • 2Dales J P, Garcia S, Bonnier P, et al. CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients[J]. Am J Clin Pathol,2003,119(3):374-380.
  • 3Wikstrom P, Lissbrant I F, Stattin P, et al. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer[J].Prostate,2002,51(4):268-275.
  • 4Duff S E, Li C, Garland J M, et al. CD105 is important for angiogenesis: evidence and potential applications[J].FASEB J,2003,17(9):984-992.
  • 5Yagasaki H, Kawata N, Takimoto Y, et al. Histopathological analysis of angiogenic factors in renal cell carcinoma[J].Int J Urol,2003,10(4):220-227.
  • 6Nakai S, Masaki T, Shiratori Y, et al. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival[J]. Int J Oncol. 2002,20(4):769-775.
  • 7Fonsatti E,Del Vecchio L,Altomonte M,et al. Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies[J]. J Cell Physiol,2001,188(1):1-7.
  • 8Neufeld G, Cohen T,Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors[J]. FASEB J,1999,13(1):9-22.
  • 9Hirohashi S, Ishiak K G,Kojiro M, et al. Hepatocellular carcinoma[A]. Hamilton S R, Aaltonen L A. World health organization classification of tumours. Pathology and genetics of tumours of the digestive system[C]. Lyon: IARC Press,2000.159-172.
  • 10Ito Y, Takeda T, Sasaki Y, et al. Expression of p57/Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma[J]. Liver, 2002,22(2):145-149.

共引文献25

同被引文献56

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部